Medsurge Ind Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 13-12-2024
- Paid Up Capital ₹ 2.50 M
as on 13-12-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -59.33%
(FY 2021)
- Profit 32.10%
(FY 2021)
- Ebitda -198.56%
(FY 2021)
- Net Worth -10.32%
(FY 2021)
- Total Assets -13.22%
(FY 2021)
About Medsurge Ind
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Nandakumar Rajagopalan, Nandakumar Padma, and Vijay Nandakumar serve as directors at the Company.
- CIN/LLPIN
U51507TN2004PTC053512
- Company No.
053512
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jun 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medsurge Ind Private Limited offer?
Medsurge Ind Private Limited offers a wide range of products and services, including Scalpels, Needles & Scissors, Biopsy Instruments, Surgical Instruments & Accessories, Surgical Needles.
Who are the key members and board of directors at Medsurge Ind?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandakumar Rajagopalan  | Director | 18-Jun-2004 | Current |
| Nandakumar Padma | Director | 18-Jun-2004 | Current |
| Vijay Nandakumar | Director | 16-Jun-2010 | Current |
Financial Performance and Corporate Structure Insights of Medsurge Ind.
Medsurge Ind Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 59.33% decrease. The company also saw a substantial improvement in profitability, with a 32.1% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medsurge Ind?
In 2018, Medsurge Ind had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Golden Chest Ventures Private LimitedActive 10 years 10 monthsNandakumar Rajagopalan, Nandakumar Padma and 1 more are mutual person
Premier Green Innovations Private LimitedActive 17 years 6 monthsNandakumar Rajagopalan is a mutual person
Goldenchest Analytics LlpActive 5 years 4 monthsNandakumar Rajagopalan and Nandakumar Padma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medsurge Ind?
Unlock and access historical data on people associated with Medsurge Ind, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medsurge Ind, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medsurge Ind's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
